BioSpace News Archive

Business

Bristol-Myers Squibb Company Selects Isis Pharmaceuticals, Inc. Drug Targeting Pcsk9 as Development Candidate for Prevention and Treatment of Cardiovascular Disease

April 8, 2008
·
4 min read
Drug Development

Arena Pharmaceuticals, Inc. Initiates Phase 2b Clinical Trial of APD125 for the Treatment of Insomnia

April 8, 2008
·
6 min read
Business

Raven Biotechnologies, Inc. Announces Collaboration With Monogram Biosciences to Advance Diagnostic Cancer Technologies

April 8, 2008
·
2 min read
Drug Development

Protox Therapeutics Inc. Initiates Phase 2 BPH Study

April 8, 2008
·
4 min read
Drug Development

Rigel Pharmaceuticals, Inc.'s R788 Shows Preclinical Activity in Type 1 Diabetes Model

April 8, 2008
·
4 min read
Deals

Chelsea Therapeutics, Inc. Gains Global Rights to I-3D Portfolio Targeting Autoimmune Disease and Transplant Rejection

April 8, 2008
·
3 min read
Drug Development

Anesiva, Inc. Announces Pivotal Phase 3 Clinical Trial of Adlea(TM) for Reducing Post-Surgical Pain Following Total Knee Replacement

April 8, 2008
·
6 min read
Roche Diagnostics Expands Availability of HCV Immunoassay

April 8, 2008
·
2 min read
FDA

Bristol-Myers Squibb Company and Otsuka Pharmaceutical Co., Ltd. Receive European Marketing Authorization for ABILIFY(R) in the Treatment and Prevention of Moderate to Severe Manic Episodes in Bipolar I Disorder

April 8, 2008
·
5 min read
Policy

Endo Pharmaceuticals Withdraws Frova Application for Menstrual Migraine

April 8, 2008
·
8 min read